TrkA
2 drugs3
approved indications
2
Approved Drugs
2
Companies
4
Indications
0
Therapeutic Areas
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (2 companies)
✓ All 2 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (4 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
Bayer 1 drug
DOMPE FARMACEUTICI 1 drug
By Therapeutic Area
Other 2 drugs
By Therapeutic Area
Other 2 drugs
STIVARGA, OXERVATE
Indications Treated
Metastatic colorectal cancerLocally advanced, unresectable or metastatic gastrointestinal stromal tumorHepatocellular carcinomaNeurotrophic Keratitis